This grant opportunity, offered by Sanofi, aims to address gaps and provide educational resources related to the diagnosis and treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). CIDP is a heterogeneous, immune-mediated neuropathy characterized by demyelination of motor and sensory nerves, leading to various clinical challenges.
Sanofi seeks proposals for educational programs, particularly those that can effectively recap information from the 2024 Peripheral Nerve Society Annual Meeting and offer independent medical education (IME) activities. Programs should focus on key evidence-based data and offer recommendations to healthcare providers dealing with CIDP, particularly in areas such as treatment options, clinical challenges, and the role of complement therapeutics in CIDP care.
